Key Takeaways
- • Megaannum Capital, the venture capital platform of Hong Kong-based Megaannum Group, and Beijing Zhongke Xianxing Venture Capital Management signed a strategic cooperation agreement on October 18, 2026 at The Peninsula Hong Kong to jointly establish a pre-IPO private equity fund.
- • The target fund size is RMB1 billion (approximately US$140 million at prevailing rates, not stated in the source).
- • Zhongke Xianxing is a venture platform under the Chinese Academy of Sciences, focused on commercializing research from the Technical Institute of Physics and Chemistry of the CAS and affiliated institutes.
- • Megaannum Group will provide support across its four segments: Megaannum Capital (PE and VC), Megaannum Asset Management, Megaannum Technology, and Megaannum AI Solutions.
- • The fund is designed to provide structured financing for technology companies moving from the laboratory to the market and to support their global expansion, with Hong Kong positioned as a bridge to international capital.
Summary
Megaannum Capital Limited, the venture capital platform of the Hong Kong SAR-based Megaannum Group, held a signing ceremony on October 18, 2026 at The Peninsula Hong Kong with Beijing Zhongke Xianxing Venture Capital Management Co., Ltd., according to a release distributed by ACN Newswire. The two parties intend to jointly establish a pre-IPO private equity fund with a target size of RMB1 billion. Joyce Lee, Chairwoman of Megaannum Group, and Dr Biao Li, Partner of Zhongke Xianxing Venture Capital, signed the strategic cooperation agreement.
Zhongke Xianxing Venture Capital is a hard-tech investment platform jointly initiated by leading Chinese research institutes and professional investors. It focuses on commercializing technological achievements from the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences and affiliated institutes, and operates under a '1+3+N' model. The release states that the firm has previously advanced fund cooperation with the University of Chinese Academy of Sciences and the Aerospace Information Research Institute.
Megaannum Group describes itself as an integrated financial technology group combining capital, technology and artificial intelligence. Its segments include Megaannum Capital, which focuses on private equity and venture capital and specializes in growth-stage and pre-IPO technology investments; Megaannum Asset Management, which provides institutional and wealth management; Megaannum Technology, which offers infrastructure and commercialization support; and Megaannum AI Solutions, which develops proprietary AI and algorithmic capabilities. Under the partnership, the group says it will provide capital, industry resources, technological support and commercialization services to the fund's portfolio companies.
Joyce Lee said the fund is intended to bring advanced technological achievements from the laboratory to the marketplace and serve as a springboard for the global expansion of incubated companies, leveraging Hong Kong's role as a bridge between Mainland China and international capital markets. Dr Biao Li characterized the partnership as a combination of scientific capability and Hong Kong capital market access. The release does not disclose the fund's closing timeline, governance structure, or capital commitments from individual parties, and figures beyond the RMB1 billion target were not provided.
Zhongke Xianxing Venture Capital is a hard-tech investment platform jointly initiated by leading Chinese research institutes and professional investors. It focuses on commercializing technological achievements from the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences and affiliated institutes, and operates under a '1+3+N' model. The release states that the firm has previously advanced fund cooperation with the University of Chinese Academy of Sciences and the Aerospace Information Research Institute.
Megaannum Group describes itself as an integrated financial technology group combining capital, technology and artificial intelligence. Its segments include Megaannum Capital, which focuses on private equity and venture capital and specializes in growth-stage and pre-IPO technology investments; Megaannum Asset Management, which provides institutional and wealth management; Megaannum Technology, which offers infrastructure and commercialization support; and Megaannum AI Solutions, which develops proprietary AI and algorithmic capabilities. Under the partnership, the group says it will provide capital, industry resources, technological support and commercialization services to the fund's portfolio companies.
Joyce Lee said the fund is intended to bring advanced technological achievements from the laboratory to the marketplace and serve as a springboard for the global expansion of incubated companies, leveraging Hong Kong's role as a bridge between Mainland China and international capital markets. Dr Biao Li characterized the partnership as a combination of scientific capability and Hong Kong capital market access. The release does not disclose the fund's closing timeline, governance structure, or capital commitments from individual parties, and figures beyond the RMB1 billion target were not provided.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.